Systematic Review

Published on 19 Feb 2024

Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis

in Gynecological Oncology

Roxana Schwab
Lina Judit Schiestl
Lorena Cascant Ortolano
Philip Herbert Klecker
Mona Wanda Schmidt
Katrin Almstedt
Anne-Sophie Heimes
Walburgis Brenner
Kathrin Stewen
Marcus Schmidt

Frontiers in Oncology

doi 10.3389/fonc.2024.1352975

2,978 views
3 citations

Original Research

Published on 15 Feb 2024

Exploring the potential prompting role of cervical human papilloma virus detection in vulvar lesions: a cross-sectional study in China

in Gynecological Oncology

Xiaoqing Dang
Quanlong Lu
Jing Li
Ruifang Li
Bo Feng
Chen Wang
Lifang Gao
Ruimei Feng
Zhilian Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1353580

1,219 views

Case Report

Published on 15 Feb 2024

Intravenous metastasis of unexpected uterine sarcoma in the context of uterine fibroids: case report and literature review

in Gynecological Oncology

Wenying Huang
Tianwei Zhang
Hui Wang
Zhengchun Liu
Peiling Zhai
Xinbo Wang
Shuai Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1354032

1,192 views

Original Research

Published on 14 Feb 2024

Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway

in Gynecological Oncology

Yasushi Iida
Nozomu Yanaihara
Yuki Yoshino
Misato Saito
Ryosuke Saito
Junya Tabata
Ayako Kawabata
Masataka Takenaka
Natsuko Chiba
Aikou Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1302850

2,020 views

Clinical Trial

Published on 12 Feb 2024

Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial

in Gynecological Oncology

Sergei Krasny
Yauheni Baranau
Sergey Polyakov
Ekaterina Zharkova
Olga Streltsova
Aliona Filimonava
Volha Siarheyeva
Sviatlana Kazlouskaya
Anton Khorau
Vladimir Gabai

Frontiers in Oncology

doi 10.3389/fonc.2024.1343023

2,185 views

Original Research

Published on 12 Feb 2024

A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years

in Gynecological Oncology

Jinhua Huang
Yu Chen
Ziyin Li
Mimi Chen
Dingwen Huang
Peixin Zhu
Xintong Han
Yi Zheng
Xiaochun Chen
Zhiying Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1343533

1,843 views

Clinical Trial

Published on 12 Feb 2024

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

in Gynecological Oncology

Denise Uyar
Chad M. Michener
Erin Bishop
Elizabeth Hopp
Pippa Simpson
Liyun Zhang
Janet S. Rader
Peter G. Rose
Haider S. Mahdi
Robert Debernardo

Frontiers in Oncology

doi 10.3389/fonc.2024.1291090

1,901 views
1 citation

Original Research

Published on 09 Feb 2024

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls

in Gynecological Oncology

Soo Jin Park
Joo-Hyuk Son
Tae-Wook Kong
Suk-Joon Chang
Hee Seung Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1203129

1,001 views
2 citations

Case Report

Published on 09 Feb 2024

Ovarian cancer with intestinal wall invasion and hyperamylasemia: a case report

in Gynecological Oncology

Yu Jie
Juan Li
Chang-feng Man
Yu Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1299226

1,311 views

Original Research

Published on 08 Feb 2024

Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome

in Gynecological Oncology

Neusha Zadeh
Arjun Bhatt
Vaishnavi Sripiparu
Melisa Pasli
George Edwards
Michael C. Larkins
M. Sean Peach

Frontiers in Oncology

doi 10.3389/fonc.2024.1296496

1,714 views

Original Research

Published on 07 Feb 2024

Predicting the recurrence of usual-type cervical adenocarcinoma using a nomogram based on clinical and pathological factors: a retrospective observational study

in Gynecological Oncology

Yuting Liu
Ningning Zhang
Qing Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1320265

1,465 views

Review

Published on 07 Feb 2024

New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

in Gynecological Oncology

Biqing Chen
Liping Zhao
Rulin Yang
Tianmin Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1329133

3,690 views
2 citations

Original Research

Published on 06 Feb 2024

Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis

in Gynecological Oncology

Limei Guo
Runmei Zhang
Yi Xu
Wenqi Wu
Qian Zheng
Jianting Li
Jun Wang
Jinliang Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1304793

987 views

Case Report

Published on 02 Feb 2024

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report

in Gynecological Oncology

Paola Giancontieri
Camilla Turetta
Giacomo Barchiesi
Angelina Pernazza
Gemma Pignataro
Giuliano D’Onghia
Daniele Santini
Federica Tomao

Frontiers in Oncology

doi 10.3389/fonc.2023.1307573

2,216 views

Original Research

Published on 02 Feb 2024

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China

in Gynecological Oncology

Jinghong Chen
Mengpei Zhang
Kemin Li
Yuanqiong Duan
Jing Zeng
Qingli Li
Danqing Wang
Liang Song
Qintong Li
Rutie Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1336616

2,544 views
2 citations

Case Report

Published on 02 Feb 2024

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer

in Gynecological Oncology

Jennifer Wolf
Nicole Goncalves
Ioannis Alagkiozidis

Frontiers in Oncology

doi 10.3389/fonc.2024.1302724

1,065 views

Navigation group

Articles

Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis

Exploring the potential prompting role of cervical human papilloma virus detection in vulvar lesions: a cross-sectional study in China

Intravenous metastasis of unexpected uterine sarcoma in the context of uterine fibroids: case report and literature review

Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway

Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial

A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls

Ovarian cancer with intestinal wall invasion and hyperamylasemia: a case report

Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome

Predicting the recurrence of usual-type cervical adenocarcinoma using a nomogram based on clinical and pathological factors: a retrospective observational study

New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer